Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: SmithKline Beecham's Coreg

Executive Summary

SmithKline Beecham's Coreg: Cardiovascular & Renal Drugs Advisory Committee is scheduled to review carvedilol for congestive heart failure on May 2. On May 3, committee will review Boehringer Mannheim's reteplase (modified recombinant tissue plasminogen activator) for use in acute myocardial infarction. The committee also is scheduled to discuss digitalis for atrial ventricular tachycardia and CHF. Location has not been announced...



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts